HTG Molecular Diagnostics, Inc. (HTGMQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 12.38 Million USD | -38.26% |
| 2021 | 20.06 Million USD | -3.15% |
| 2020 | 20.71 Million USD | -2.06% |
| 2019 | 21.14 Million USD | -6.74% |
| 2018 | 22.67 Million USD | -6.73% |
| 2017 | 24.31 Million USD | 1.12% |
| 2016 | 24.04 Million USD | 6.62% |
| 2015 | 22.55 Million USD | -31.17% |
| 2014 | 32.76 Million USD | 22.06% |
| 2013 | 26.84 Million USD | 0.58% |
| 2012 | 26.69 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | 10.39 Million USD | -16.11% |
| 2023 Q2 | - USD | -100.0% |
| 2022 Q1 | 17.19 Million USD | -14.28% |
| 2022 FY | 12.38 Million USD | -38.26% |
| 2022 Q2 | 16.63 Million USD | -3.26% |
| 2022 Q4 | 12.38 Million USD | -0.13% |
| 2022 Q3 | 12.4 Million USD | -25.45% |
| 2021 Q2 | 18.87 Million USD | -4.59% |
| 2021 Q1 | 19.78 Million USD | -4.47% |
| 2021 FY | 20.06 Million USD | -3.15% |
| 2021 Q3 | 19.62 Million USD | 3.92% |
| 2021 Q4 | 20.06 Million USD | 2.25% |
| 2020 Q4 | 20.71 Million USD | 1.0% |
| 2020 Q2 | 20.61 Million USD | 3.03% |
| 2020 Q1 | 20.01 Million USD | -5.37% |
| 2020 FY | 20.71 Million USD | -2.06% |
| 2020 Q3 | 20.5 Million USD | -0.53% |
| 2019 Q1 | 20.38 Million USD | -10.13% |
| 2019 Q4 | 21.14 Million USD | -7.28% |
| 2019 Q2 | 23.45 Million USD | 15.08% |
| 2019 FY | 21.14 Million USD | -6.74% |
| 2019 Q3 | 22.81 Million USD | -2.74% |
| 2018 Q1 | 22.37 Million USD | -7.98% |
| 2018 FY | 22.67 Million USD | -6.73% |
| 2018 Q3 | 22.12 Million USD | 1.43% |
| 2018 Q4 | 22.67 Million USD | 2.52% |
| 2018 Q2 | 21.8 Million USD | -2.53% |
| 2017 Q1 | 22.35 Million USD | -7.02% |
| 2017 FY | 24.31 Million USD | 1.12% |
| 2017 Q4 | 24.31 Million USD | 11.76% |
| 2017 Q3 | 21.75 Million USD | 2.83% |
| 2017 Q2 | 21.15 Million USD | -5.37% |
| 2016 Q1 | 29.18 Million USD | 29.42% |
| 2016 Q2 | 27.65 Million USD | -5.26% |
| 2016 Q3 | 25.4 Million USD | -8.14% |
| 2016 Q4 | 24.04 Million USD | -5.34% |
| 2016 FY | 24.04 Million USD | 6.62% |
| 2015 FY | 22.55 Million USD | -31.17% |
| 2015 Q1 | 82.25 Million USD | 151.01% |
| 2015 Q4 | 22.55 Million USD | 2.02% |
| 2015 Q3 | 22.1 Million USD | 1.29% |
| 2015 Q2 | 21.82 Million USD | -73.47% |
| 2014 Q4 | 32.76 Million USD | -10.74% |
| 2014 Q1 | - USD | -100.0% |
| 2014 Q2 | 11.78 Million USD | 0.0% |
| 2014 Q3 | 36.7 Million USD | 211.61% |
| 2014 FY | 32.76 Million USD | 22.06% |
| 2013 Q4 | 26.84 Million USD | 0.0% |
| 2013 FY | 26.84 Million USD | 0.58% |
| 2012 FY | 26.69 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -243.292% |
| Arrayit Corporation | 7.49 Million USD | -65.221% |
| Atlantic International Corp. | 3.82 Million USD | -223.51% |
| Biocept, Inc. | 22.01 Million USD | 43.733% |
| Bioqual, Inc. | 18.93 Million USD | 34.597% |
| CardioGenics Holdings Inc | 1.79 Million USD | -590.055% |
| DermTech, Inc. | 64.75 Million USD | 80.873% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 98.315% |
| iMD Companies, Inc. | 1.67 Million USD | -639.806% |
| IDenta Corp. | 1.01 Million USD | -1122.51% |
| Interpace Biosciences, Inc. | 28.15 Million USD | 56.011% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -4057.101% |
| InVitro International | 78.99 Thousand USD | -15580.413% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | 37.22% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -9479.463% |
| Medical Imaging Corp. | 9.51 Million USD | -30.144% |
| NovelStem International Corp. | 4.2 Million USD | -194.478% |
| Optigenex Inc. | 9.57 Million USD | -29.416% |
| PharmChem, Inc. | 558.64 Thousand USD | -2117.135% |
| Proteome Sciences plc | 18.48 Million USD | 33.009% |
| Response Genetics, Inc | 15.86 Million USD | 21.939% |
| Rennova Health, Inc. | 49.66 Million USD | 75.062% |
| RushNet, Inc. | 6.23 Million USD | -98.525% |
| ScreenPro Security Inc. | 1.6 Million USD | -673.838% |
| Stella Diagnostics Inc. | 18 Million USD | 31.21% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | -50.975% |
| Todos Medical Ltd. | 50.15 Million USD | 75.306% |